GSK plc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Thanks, everybody. Thanks for joining us this morning and making it to the third company day, fourth day overall of the conference here at Bank of America. So it's my pleasure to introduce the first session. We've got Emma Walmsley, CEO of GlaxoSmithKline. Also sitting in the front row here, also, Iain, the CFO as well.
I think probably the best thing is, Emma, if you want to make some opening remarks, and then we'll dive straight into Q&A. As a reminder, if you've got a question, please raise your hand and just wait for the microphone, but I've got plenty otherwise. So over to you, Emma.
No doubt. Well, thank you very much for having me, and a big thank you to those of you knowing that you can access all of this online. It's pretty good to see you and it's Friday, so thanks for coming in this morning.
Just a few opening remarks. Obviously, GSK has been through an enormous change
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
